SEC
SlamSEC
SearchBrowseEarnings

Replimune Group, Inc.

Nasdaq:REPL
Biological Products, (No Diagnostic Substances)·WOBURN, MA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(588 total)

TypeDateAccessionPeriodSize
4
Feb 20, 2026
0001104659-26-018159OWNERSHIP DOCUMENT
Feb 18, 2026
4.4 KB
SCHEDULE 13G/A
Feb 17, 2026
0001193125-26-053163
—
8.9 KB
10-Q
Feb 3, 2026
0001628280-26-00480510-Q
Dec 31, 2025
8.5 MB
8-K
Feb 3, 2026
0001104659-26-009510FORM 8-K
Feb 3, 2026
255.9 KB
8-K
Jan 12, 2026
0001104659-26-002721FORM 8-K
Jan 12, 2026
5.1 MB
4
Dec 19, 2025
0001104659-25-123290OWNERSHIP DOCUMENT
Dec 19, 2025
5.0 KB
4
Dec 19, 2025
0001104659-25-123286OWNERSHIP DOCUMENT
Dec 19, 2025
5.0 KB
4
Dec 19, 2025
0001104659-25-123285OWNERSHIP DOCUMENT
Dec 19, 2025
5.0 KB
4
Dec 19, 2025
0001104659-25-123282OWNERSHIP DOCUMENT
Dec 19, 2025
5.0 KB
4
Dec 19, 2025
0001104659-25-123279OWNERSHIP DOCUMENT
Dec 19, 2025
5.0 KB
4
Dec 11, 2025
0001104659-25-120332OWNERSHIP DOCUMENT
Dec 9, 2025
8.3 KB
144
Dec 9, 2025
0001968582-25-001182
—
4.1 KB
4
Dec 4, 2025
0001104659-25-118483OWNERSHIP DOCUMENT
Dec 2, 2025
5.6 KB
144
Dec 2, 2025
0001968582-25-001147
—
4.3 KB
4
Nov 19, 2025
0001104659-25-114124OWNERSHIP DOCUMENT
Nov 17, 2025
5.6 KB
4
Nov 19, 2025
0001104659-25-114122OWNERSHIP DOCUMENT
Nov 17, 2025
5.6 KB
SCHEDULE 13G/A
Nov 14, 2025
0001104659-25-112548
—
10.8 KB
SCHEDULE 13G/A
Nov 14, 2025
0000902664-25-005014
—
11.8 KB
SCHEDULE 13G/A
Nov 14, 2025
0000080255-25-000829
—
7.3 KB
SCHEDULE 13G
Nov 14, 2025
0001493215-25-000047
—
12.1 KB
S-3/A
Nov 6, 2025
0001104659-25-107762S-3/A
—
734.2 KB
8-K
Nov 6, 2025
0001104659-25-107438FORM 8-K
Nov 6, 2025
255.5 KB
10-Q
Nov 6, 2025
0001628280-25-04988410-Q
Sep 30, 2025
7.3 MB
8-K
Oct 20, 2025
0001104659-25-100605FORM 8-K
Oct 20, 2025
199.9 KB
8-K
Sep 18, 2025
0001104659-25-091066FORM 8-K
Sep 16, 2025
201.0 KB
25 filings shown
CEO
Patel Sushil
CFO
Hill Emily Luisa